Compared with younger women, older women who undergo combined surgery for pelvic organ prolapse (POP) and stress urinary incontinence (SUI) are almost twice as likely to experience SUI (but not POP) treatment failure.
Compared with younger women, older women who undergo combined surgery for pelvic organ prolapse (POP) and stress urinary incontinence (SUI) are almost twice as likely to experience SUI (but not POP) treatment failure.
However, older women report just as significant an improvement in symptoms and effect on quality of life as younger women do, according to the findings of a retrospective cohort study involving 122 women younger than 65 years of age and 70 women 65 years of age or older.
After a median follow-up time of almost 1 year, no significant difference existed between the 2 groups.
Twenty-one percent of the older women and 11% of the younger women reported SUI treatment failure (adjusted odds ratio [AOR], 1.10; 95% confidence interval [CI], 1.05-2.5), whereas 13% of the older women and 9% of the younger women reported POP treatment failure (AOR, 0.90; 95% CI, 0.29-2.8).
Sung VW, Joo K, Marques F, Myers DL. Patient-reported outcomes after combined surgery for pelvic floor disorders in older compared to younger women. Am J Obstet Gynecol. 2009;201(5):534. e1-e5.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More